RE:RE:RE:RE:Don't sell your shares!Long term share holders all know the prospects in terms of PMX, history, in terms of previous results as well as new TIGRIS trial with enough leeway to allow them to do a proper job of it, all the numbers from Japan and Italy and previous study there and now with selected patients being enrolled at a steady clip, it is as good as it is going to get.. Today's news release was totally unexpected since the management had made it clear that they were not going to jeopardize the trial and run afoul with FDA by issuing any premature results..
And let's not forget that Spectral is not a one trick poney.. Dialco with already approved SAMI and pretty soon the DIMI we have a subsidiary that is worth any where from half a billion to as much as 2 billion if previous deals are any guide.. We already have one deal and with the new guy, whose claim to fame is his rolodex with access to all manners of right people, we are going to be surprised one of these days with some other deals.. Hopefully..
So who in their right mind would sell the shares where the marketcap is a lousy 150+ million..
No doubt, The game is afoot.. Every news release that comes out of the company will be looked over closely and parsed for sure.. Breakthrough Device designation and if we have interim results at some point that blows out the numbers, anything is possible..
FWIW
p.s. And yes, a .01 move in shares is worth a lot of money, up or down, for some of the players here so let's not even go there.. :)